• Featured Product
  • KD/KO Validated

C9orf72 Polyclonal antibody

C9orf72 Polyclonal Antibody for IF, IHC, WB,ELISA

Host / Isotype

Rabbit / IgG


human, mouse and More (1)





Cat no : 25757-1-AP


C9orf72, C9RANT

Tested Applications

Positive WB detected inmouse brain tissue, HEK-293 cells, SH-SY5Y cells
Positive IHC detected inhuman gliomas tissue, human testis tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF detected inmouse brain tissue

Recommended dilution

Western Blot (WB)WB : 1:300-1:1500
Immunohistochemistry (IHC)IHC : 1:500-1:2000
Immunofluorescence (IF)IF : 1:50-1:500
Sample-dependent, check data in validation data gallery

Product Information

The immunogen of 25757-1-AP is C9orf72 Fusion Protein expressed in E. coli.

Tested Reactivity human, mouse
Cited Reactivityhuman, rat
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen C9orf72 fusion protein Ag22723
Full Name chromosome 9 open reading frame 72
Calculated molecular weight 481 aa, 54 kDa
Observed molecular weight 25-30 kDa
GenBank accession numberBC068445
Gene symbol C9orf72
Gene ID (NCBI) 203228
Conjugate Unconjugated
Form Liquid
Purification Method Antigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

C9ORF72 has a domain whith polymorphic hexanucleotide repeat (GGGGCC). The C9ORF72-hexanucleotide repeat expansions have been recently identified as genetic markers in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). The C9ORF72 repeat expansions may indicate a worse prognosis in ALS. Human C9ORF72 has some isoforms with MW 54-60 kDa and 25-30 kDa. Mouse C9orf72 has some isoforms with MW 50-60 kDa and 35 kDa. This antibody detects the N-terminal of C9orf72.


Product Specific Protocols
WB protocol for C9orf72 antibody 25757-1-APDownload protocol
IHC protocol for C9orf72 antibody 25757-1-APDownload protocol
IF protocol for C9orf72 antibody 25757-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols



Nat Med

Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons.

Authors - Yingxiao Shi


Implementation of an antibody characterization procedure and application to the major ALS/FTD disease gene C9ORF72.

Authors - Carl Laflamme

Acta Neuropathol

An interaction between synapsin and C9orf72 regulates excitatory synapses and is impaired in ALS/FTD.

Authors - Claudia S Bauer


C9orf72 regulates the unfolded protein response and stress granule formation by interacting with eIF2α

Authors - Wenzhong Zheng

Front Cell Neurosci

Loss of TMEM106B exacerbates C9ALS/FTD DPR pathology by disrupting autophagosome maturation

Authors - Claudia S Bauer